triple glp 1 agonist 🎙️ NEW EPISODE: Retatrutide—The *Not licensed* Will this replace the current GLP-1 in the market. This triple receptor agonist (GIP/ GLP-1/glucagon) is showing unprecedented results in weight loss trials, outperforming current Weight-Loss Drug Use Has LY3437943 Size:20 Servings

triple glp 1 agonist 🎙️ NEW EPISODE: Retatrutide—The *Not licensed* Will this replace the current GLP-1 in the market. This triple receptor agonist (GIP/ GLP-1/glucagon) is showing unprecedented results in weight loss trials, outperforming current Weight-Loss Drug Use Has LY3437943 Size:20 Servings

Weight-Loss Drug Use Has Risen Sharply Among Children and Adults With Type 1 Diabetes | Johns Hopkins | Bloomberg School of Public Health

Although Semaglutide GLP-1 starts acting soon after injection, most people don’t notice significant effects immediately

LY3437943

Size:20 Servings

The Effect of Exenatide Once Weekly on Carotid Atherosclerosis in Individuals With Type 2 Diabetes: An 18-Month Randomized Placebo-Controlled Study